p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases - PubMed (original) (raw)
. 2003 Oct 31;278(44):43586-94.
doi: 10.1074/jbc.M307194200. Epub 2003 Aug 19.
Affiliations
- PMID: 12930830
- DOI: 10.1074/jbc.M307194200
Free article
p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases
Chinweike Ukomadu et al. J Biol Chem. 2003.
Free article
Abstract
Mevastatin arrested HCT116 colon cancer cells at the G1/S transition and increased cellular levels of p21CIP1/WAF1. p21-deficient colon cancer cells continued to proliferate in the presence of mevastatin. Although p21 was necessary for the G1/S block, the G1 cyclin-dependent kinases (Cdks) cyclin E-Cdk2 and cyclin D-Cdk4 remained active. Despite the activity of the G1 Cdks the retinoblastoma protein was hypophosphorylated due to unknown mechanisms that were dependent on the p21 protein. The resulting decrease in cyclin A mRNA and protein led to a decrease in the activity of cyclin A-Cdk2. Therefore, although p21 was required for the G1/S arrest of HCT116 colon cancer cells by mevastatin, its mode of action was more complicated than the simple formation of a physical complex with cyclin-Cdk2. This mechanism of inhibition is different from that seen in prostate cancer cells (Ukomadu, C., and Dutta, A. (2003) J. Biol. Chem. 278, 4840-4846) where the activating phosphorylation of cyclin E-Cdk2 is suppressed and p21 is not required, suggesting the existence of cell line-specific differences in the mechanism by which statins arrest the cell cycle.
Similar articles
- Inhibition of cdk2 activating phosphorylation by mevastatin.
Ukomadu C, Dutta A. Ukomadu C, et al. J Biol Chem. 2003 Feb 14;278(7):4840-6. doi: 10.1074/jbc.M208658200. Epub 2002 Dec 9. J Biol Chem. 2003. PMID: 12475985 - Apoptosis and the cell cycle.
Chiarugi V, Magnelli L, Cinelli M, Basi G. Chiarugi V, et al. Cell Mol Biol Res. 1994;40(7-8):603-12. Cell Mol Biol Res. 1994. PMID: 7787878 Review. - Policing Cancer: Vitamin D Arrests the Cell Cycle.
Bhoora S, Punchoo R. Bhoora S, et al. Int J Mol Sci. 2020 Dec 6;21(23):9296. doi: 10.3390/ijms21239296. Int J Mol Sci. 2020. PMID: 33291213 Free PMC article. Review.
Cited by
- Longitudinal cohort study highlights cancer-preventive benefits of lipid-lowering drugs.
Yuan Z, Ding C, Duan J, Lian R, Shi Y, Han J, Dong H, Song Y, Zhao J, Fan X. Yuan Z, et al. iScience. 2024 Aug 6;27(9):110680. doi: 10.1016/j.isci.2024.110680. eCollection 2024 Sep 20. iScience. 2024. PMID: 39252980 Free PMC article. - Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma.
Santos JC, Profitós-Pelejà N, Ribeiro ML, Roué G. Santos JC, et al. Cancers (Basel). 2022 Nov 15;14(22):5601. doi: 10.3390/cancers14225601. Cancers (Basel). 2022. PMID: 36428695 Free PMC article. - Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer.
Alfaleh MA, Fahmy O, Al-Rabia MW, Abourehab MAS, Ahmed OAA, Fahmy UA, H Alsulimani H, Badr-Eldin SM, Aldawsari HM, Aldhabi BM, Alharbi AS, Alhakamy NA. Alfaleh MA, et al. Sci Rep. 2022 Nov 14;12(1):19446. doi: 10.1038/s41598-022-24151-3. Sci Rep. 2022. PMID: 36376469 Free PMC article. - Anti-Proliferative Effect of Statins Is Mediated by DNMT1 Inhibition and p21 Expression in OSCC Cells.
Dongoran RA, Wang KH, Lin TJ, Yuan TC, Liu CH. Dongoran RA, et al. Cancers (Basel). 2020 Jul 28;12(8):2084. doi: 10.3390/cancers12082084. Cancers (Basel). 2020. PMID: 32731382 Free PMC article. - TASK-3 Downregulation Triggers Cellular Senescence and Growth Inhibition in Breast Cancer Cell Lines.
Zúñiga R, Valenzuela C, Concha G, Brown N, Zúñiga L. Zúñiga R, et al. Int J Mol Sci. 2018 Mar 29;19(4):1033. doi: 10.3390/ijms19041033. Int J Mol Sci. 2018. PMID: 29596383 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources